Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Clinical trial NCT03025256 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03025256
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acral Lentiginous Melanoma Central Nervous System Melanoma Clinical Stage IV Cutaneous Melanoma AJCC v8 Leptomeningeal Neoplasm Melanocytoma Metastatic Lung Non-Small Cell Carcinoma Metastatic Melanoma Metastatic Mucosal Melanoma Metastatic Uveal Melanoma Stage IV Lung Cancer AJCC v8

Start date: 2018-05-02
Primary completion: 2027-06-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.